Board of Directors
Jeffrey D. GoldbergCo-Chairman of the Board Vice President, EnerSys Advanced Systems
Mr. Goldberg is the Vice President of EnerSys Advanced Systems, the advanced technology division of EnerSys, which is one of the world’s leading providers of stored-energy solutions. Before that, Mr. Goldberg served as the president of IncuMed, the technology incubator for Al Mann's development-level companies (including companies pursuing drug-device combinations to treat tinnitus and diabetes as well as advanced technologies supporting defense and intelligence agencies). His prior experience includes executive management positions in the health care industry, including Advanced Bionics Corporation, Los Angeles Orthopaedic Hospital (in alliance with UCLA Healthcare), and the Doheny Eye Institute (affiliated with the UCLA School of Medicine). He has also worked as an M&A lawyer for Occidental Petroleum Corporation, O'Melveny & Myers, LLP, and McDermott, Will & Emery, LLP. Mr. Goldberg also currently serves as the chair of the board of Physiotherapy Associates, one of the nation’s leading providers of physical therapy services.
Since January 2008, Mr. Cellar has been a consultant and board member to companies in a variety of industries as well as a private investor. From 1999 to 2008 Mr. Cellar worked for the hedge fund Bay Harbour Management, L.C. He was partner and portfolio manager from 2003 until his departure. During his tenure at Bay Harbour, the fund won many investor awards including The Absolute Return "Hedge Fund of the Year" award in 2006. Prior to Bay Harbour, Mr. Cellar was with the private equity firm Remy Investors. Before that, he was a strategy consultant at LEK/Alcar. He is currently a director of Aventine Renewable Energy, Hawaiian Telcom, Six Flags Entertainment (NYSE: Six), US Concrete (NASDAQ: USCR) and Vertis Communications. Mr. Cellar has a Masters in Business Administration from the Wharton School of Business and a BA in Economics/Business from the University of California, Los Angeles. Mr. Cellar is a Chartered Financial Analyst.
Mr. Karro is a principal of Hillcote Advisors, a firm focused on investing in and restructuring healthcare companies. Prior to founding Hillcote, Mr. Karro held a number of senior executive positions in the healthcare industry, including serving as Executive Vice President of Caremark Rx, a prescription benefit management company. Mr. Karro served at Caremark Rx from 1998 through 2007 and during his time at Caremark Rx, he was responsible for mergers & acquisitions, integration planning, information technology and Medicare product development. Mr. Karro was also appointed as a charter member of the Governor’s e-Health Advisory Council in Tennessee, an organization established to coordinate Tennessee’s initiatives leading towards the adoption of electronic medical records. Mr. Karro is currently a member of the Board of Directors of Angiotech Pharmaceuticals, Inc., where he chairs the Audit Committee. Mr. Karro is also currently on the Board of Directors of Healthways, Inc. where he serves as Chairman of the Strategic Review Committee. Mr. Karro previously served on the Board of Directors of Emageon Inc. Mr. Karro received his B.A. in Honors Business Administration from the University of Western Ontario.
Donald M. Casey JrMember of the Board Chief Executive Officer, Medical Segment at Cardinal Health
Mr. Casey has over 25 years of global healthcare experience and an outstanding track record in identifying and commercializing medical innovations. Mr. Casey is currently the CEO of the Medical Segment at Cardinal Health. Mr. Casey joined Cardinal Health April 2012. Prior to that Mr. Casey held the position of CEO and a member of the Board at the West Wireless Health Institute where he drove the development of a world-class research organization focused on accelerating wireless health innovations to lower health care costs.
Previously, Mr. Casey served as Worldwide Chairman for Johnson & Johnson's comprehensive care group and member of the Company's Executive committee, where he oversaw its cardiovascular, diagnostic, diabetes and vision care franchises around the world. He was responsible for defining a corporate-wide comprehensive approach to chronic disease management, including leading the development of patient centric solutions and innovations within the medical device segment for some of the world's most pervasive conditions, including diabetes and cardiovascular disorders. Mr. Casey began his career with Johnson & Johnson in 1985, advancing into executive positions throughout the company's consumer, pharmaceutical and medical device franchises.
Mr. Casey holds an MBA from the University of Notre Dame.
Omar VaishnaviMember of the Board Head of Distressed Research, BlueMountain Capital Management
Mr. Vaishnavi is currently a Senior Investment Analyst with BlueMountain Capital Management in New York, where he principally focuses on investing in credit and equities in a variety of industries. Prior to joining BlueMountain, Mr. Vaishnavi spent several years at Silver Point Capital as an investment professional with a primary focus on healthcare and distressed investing. Before that he was an investment banking analyst with UBS. Mr. Vaishnavi graduated Magna Cum Laude with a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania.
Richard A. PackerMember of the Board Chief Executive Officer, Zoll Medical Corporation
Mr. Packer joined the board in 2014. He is currently the CEO at Zoll Medical Corporation, a leader in medical products and solftware solutions. Mr. Packer joined Zoll in 1992 as the Vice President of Operations and has served the company in a number of senior executive positions since. Prior to 1992, he was Vice President of various functions at Whistler Corporation, a consumer electronics company. Mr. Packer holds an MBA from the Harvard Business School, as well as an engineering degree from Rensselaer Polytechnic Institute.